Gene · 3693
Papers1,722
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,722
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of arachidonic acid metabolism in intervertebral disc degeneration: identification of potential biomarkers and therapeutic targets via multi-omics analysis and artificial intelligence strategies. | Lipids Health Dis | 2023 | 38007425 | PubTator, text mining | PubMed |
| Expanded phenotypic spectrum of FOXL2 Variant c.672_701dup revealed by whole-exome sequencing in a rare blepharophimosis, ptosis, and epicanthus inversus syndrome family. | BMC Ophthalmol | 2023 | 37932670 | PubTator, text mining | PubMed |
| Flaviviruses in AntiTumor Therapy. | Viruses | 2023 | 37896752 | PubTator, text mining | PubMed |
| Integrin β5 is an independent prognostic marker for intrahepatic cholangiocarcinoma in a Chinese population. | Exp Ther Med | 2023 | 37869645 | PubTator, text mining | PubMed |
| miR-3200 accelerates the growth of liver cancer cells by enhancing Rab7A. | Noncoding RNA Res | 2023 | 37860266 | PubTator, text mining | PubMed |
| Machine learning developed a PI3K/Akt pathway-related signature for predicting prognosis and drug sensitivity in ovarian cancer. | Aging (Albany NY) | 2023 | 37851341 | PubTator, text mining | PubMed |
| Glucocorticoid Receptor Activation in Lobular Breast Cancer Is Associated with Reduced Cell Proliferation and Promotion of Metastases. | Cancers (Basel) | 2023 | 37835373 | PubTator, text mining | PubMed |
| Efferocytosis and Respiratory Disease. | Int J Mol Sci | 2023 | 37834319 | PubTator, text mining | PubMed |
Two-Dimensional Polyacrylamide Gel Electrophoresis Coupled with Nanoliquid Chromatography-Tandem Mass Spectrometry-Based Identification of Differentially Expressed Proteins and Tumorigenic Pathways in the MCF7 Breast Cancer Cell Line Transfected for Jumping Translocation Breakpoint Protein Overexpression. | Int J Mol Sci | 2023 | 37834160 | PubTator, text mining | PubMed |
| Single-Cell Profiling of Cells in the Lung of a Patient with Chronic Hypersensitivity Pneumonitis Reveals Inflammatory Niche with Abundant CD39+ T Cells with Functional ATPase Phenotype: A Case Study. | Int J Mol Sci | 2023 | 37833889 | PubTator, text mining | PubMed |
| Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. | Mol Cancer | 2023 | 37833788 | PubTator, text mining | PubMed |
| Overexpression of FRA1 (FOSL1) Leads to Global Transcriptional Perturbations, Reduced Cellular Adhesion and Altered Cell Cycle Progression. | Cells | 2023 | 37830558 | PubTator, text mining | PubMed |
| New insight into the role of fibroblasts in the epithelial immune microenvironment in the single-cell era. | Front Immunol | 2023 | 37809065 | PubTator, text mining | PubMed |
| Identification of basement membrane markers in diabetic kidney disease and immune infiltration by using bioinformatics analysis and experimental verification. | IET Syst Biol | 2023 | 37776100 | PubTator, text mining | PubMed |
| Profiling of microRNA as a tool to introduce rAAV vectors in gene therapy of breast cancer: A preliminary report. | Adv Clin Exp Med | 2023 | 37771218 | PubTator, text mining | PubMed |
| Curved adhesions mediate cell attachment to soft matrix fibres in three dimensions. | Nat Cell Biol | 2023 | 37770566 | PubTator, text mining | PubMed |
| LOXL2 in Cancer: A Two-Decade Perspective. | Int J Mol Sci | 2023 | 37762708 | PubTator, text mining | PubMed |
| Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers. | Int J Mol Sci | 2023 | 37762559 | PubTator, text mining | PubMed |
| Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 37752146 | PubTator, text mining | PubMed |
| Elevated extracellular calcium ions accelerate the proliferation and migration of HepG2 cells and decrease cisplatin sensitivity. | J Biomed Res | 2023 | 37750331 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3693/papers?page=7